Hepatitis-associated antigen and cirrhosis in Uganda

Insights from a methylome-wide association study of antidepressant exposure.

Nature communications·2025

Evaluation of an extensive tuberculosis contact investigation in an urban community and jail.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2003

Hepatocellular carcinoma: an overview.

Histopathology·2001

Development of a pollution prevention and energy efficiency clearinghouse for biomedical research facilities.

Environmental health perspectives·2000

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Role of the immune microenvironment in bone regeneration and progress in immune-modulating bone nanobiomaterials.

Journal of Zhejiang University. Science. B·2026

Alizarin Red perturbs skeletal patterning and biomineralization via catalase inhibition.

Development (Cambridge, England)·2026

Enhancement of immune responses using a self-assembled lentinan nano-adjuvant.

Journal of materials chemistry. B·2026

3D-printed multifunctional composite scaffolds incorporating copper ions/amoxicillin/hydroxyapatite for synergistic antibacterial and vascularized bone regeneration.

Materials today. Bio·2026

A hierarchical, pH-responsive nanocomposite hydrogel platform for synergistic microenvironment reprogramming and attenuation of inflammatory periodontal bone loss.

Bioactive materials·2026

A sapropel-derived Lactiplantibacillus plantarum with antimicrobial activity improves intestinal architecture and remodels gut microbiota.

Frontiers in microbiology·2026

Related Experiment Videos

Hepatitis-associated antigen and cirrhosis in Uganda

Related Concept Videos

Insights from a methylome-wide association study of antidepressant exposure.

Evaluation of an extensive tuberculosis contact investigation in an urban community and jail.

Hepatocellular carcinoma: an overview.

Development of a pollution prevention and energy efficiency clearinghouse for biomedical research facilities.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Role of the immune microenvironment in bone regeneration and progress in immune-modulating bone nanobiomaterials.

Alizarin Red perturbs skeletal patterning and biomineralization via catalase inhibition.

Enhancement of immune responses using a self-assembled lentinan nano-adjuvant.

3D-printed multifunctional composite scaffolds incorporating copper ions/amoxicillin/hydroxyapatite for synergistic antibacterial and vascularized bone regeneration.

A hierarchical, pH-responsive nanocomposite hydrogel platform for synergistic microenvironment reprogramming and attenuation of inflammatory periodontal bone loss.

A sapropel-derived Lactiplantibacillus plantarum with antimicrobial activity improves intestinal architecture and remodels gut microbiota.

Related Experiment Videos

Hepatitis-associated antigen and cirrhosis in Uganda

Related Concept Videos

Related Articles